Pay in 4 interest-free payments of $6.11 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Reference: Senolytic Peptide FOXO4-DRI Selectively Removes Senescent Cells From in vitro Expanded Human Chondrocytes (2021)
In preclinical and in vitro research, GHK-Cu has demonstrated a range of biological activities, including modulation of inflammatory cytokines and influence on cellular signalling pathways
Request an Evidence-Informed Consultation Call 203-348-8805 or contact Optimal Health Medical to discuss your symptoms, goals, current evidence and appropriate next steps
Personal Opinion: Having worked with multiple peptide suppliers over the years, I find that the companies willing to share detailed COA documentation tend to be the ones producing consistently reliable products
Disclaimer: This product is intended for research use only (RUO)
Less Pain, More Play for Seniors Older adults in Riverview and Downtown Tampa report improved joint mobility and energy levels after beginning peptide therapy
US$ 26.60
US$ 29.69
US$ 20.74
US$ 24.65
US$ 25.64
US$ 26.51
